SCHEMBL6193060

SCHEMBL6193060

CC(=O)N(C(C)=O)C(C)c1c2n(c3c(C)c(Cl)ccc13)C(=O)c1ccccc1-2

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6193808 0.83 MAT2A (0.35) MAT2AALDH1A1KMT2ALMNA
SCHEMBL5093112 0.80 MAT2A (0.40) MAT2AALDH1A1KMT2ALMNA
SCHEMBL6193055 0.77 PDE10A (0.40) MAT2AALDH1A1LMNACYP1A2POLB
SCHEMBL5089800 0.75 GLA (0.32) KMT2A
SCHEMBL5094657 0.74 MAT2A (0.38) MAT2AALDH1A1LMNACYP1A2POLB
SCHEMBL6193804 0.71 MTNR1A (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL5093132 0.70 MAT2A (0.34) MAT2AALDH1A1KMT2ALMNA
SCHEMBL5767358 0.70 MAT2A (0.41) MAT2AALDH1A1LMNAPOLB
SCHEMBL5094654 0.68 ELANE (0.32) MAT2AALDH1A1KMT2ALMNA
SCHEMBL5101431 0.68 DNMT1 (0.38) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517909-A2 NOVEL TETRACYCLIC ARYLCARBONYL INDOLES HAVING SEROTONIN RECEPTOR AFFINITY USEFUL AS THERAPEUTIC AGENTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Suven Life Sciences Limited (IN) 2005-03-30 — — EP disclosed
WO-2004000205-A2 NOVEL TETRACYCLIC ARYLCARBONYL INDOLES HAVING SEROTONIN RECEPTOR AFFINITY USEFUL AS THERAPEUTIC AGENTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SUVEN LIFE SCIENCES LIMITED (IN) 2003-12-31 — — WO disclosed
Send feedback